Improving the health of the drugs industry
By Liu Jie | China Daily | Updated: 2013-04-11 07:19
|
An employee at Eli Lilly and Co's China Research and Development Center. The US-based international drugmaker puts 20 percent of its sales revenue into R&D every year and set up an R&D center in Shanghai last May. Provided to China Daily |
Eli Lilly chief Lechleiter sees China as the company's most promising market
Photo
